UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061714
Receipt number R000070622
Scientific Title Myoelectric hand prosthesis for congenital transverse failure
Date of disclosure of the study information 2026/05/28
Last modified on 2026/05/28 07:18:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prosthesis for congenital transverse failure

Acronym

Prosthesis research

Scientific Title

Myoelectric hand prosthesis for congenital transverse failure

Scientific Title:Acronym

Hand prosthesis research

Region

Japan


Condition

Condition

Congenital transverse failure

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Congenital transverse failure causes not only cosmetic problems but also functional, postural, and skeletal impairments, including scoliosis and limitations in daily and cultural activities. Because regeneration of a normal upper limb is currently impossible, myoelectric prostheses are considered a promising means of replacing lost motor and sensory functions.
Therefore, this study aims to establish non-invasive measurement and signal-processing technologies for myoelectric prostheses controlled by surface electromyographic signals, thereby providing a technological foundation for future functional upper-limb replacement.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Functional assessment performed every six months after myoelectric prosthesis applying (number of blocks transferred in the Box and Block Test)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

For patients with congenital transverse failure, individualized prostheses will be fabricated and fitted according to each case. Functional evaluations will be performed during the initial period after fitting and then every six months for approximately three years.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

5 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with congenital transverse failure (including transradial and transhumeral deficiencies) who provide written informed consent for participation in this study.

Key exclusion criteria

Patients with intellectual or developmental disabilities, as well as those deemed unsuitable for participation at the discretion of the investigator.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Takehiko
Middle name
Last name Takagi

Organization

National Center for Child Health and Development

Division name

Division of Orthopaedic Surgery

Zip code

157-8535

Address

2-10-1 Okura, Setagaya-ku, Tokyo

TEL

0334160181

Email

takagi-t@ncchd.go.jp


Public contact

Name of contact person

1st name Takehiko
Middle name
Last name Takagi

Organization

National Center for Child Health and Development

Division name

Division of Orthopaedic Surgery

Zip code

157-8535

Address

2-10-1 Okura, Setagaya-ku, Tokyo

TEL

0334160181

Homepage URL


Email

takagi-t@ncchd.go.jp


Sponsor or person

Institute

National Center for Child Health and Development

Institute

Department

Personal name



Funding Source

Organization

National Center for Child Health and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Center for Child Health and Development

Address

2-10-1 Okura, Setagaya-ku, Tokyo

Tel

0334160181

Email

takagi-t@ncchd.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

東京都


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 06 Month 02 Day

Date of IRB

2014 Year 06 Month 02 Day

Anticipated trial start date

2014 Year 06 Month 02 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 28 Day

Last modified on

2026 Year 05 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070622